Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Tampa Bay’s real estate market is entering a rare sweet spot in 2026—balancing rising inventory, steady demand, and booming commercial development. With housing supply up to 4.3 months and prices stabilizing, the region is shifting from frenzy to sustainable growth. Population migration, modernized commercial spaces, and lifestyle-focused districts like Water Street and Midtown continue to fuel Tampa’s evolution. But even amid luxury expansion, affordability remains the top challenge shaping the next phase of opportunity for real estate professionals.
Each year, AZ Big Media spotlights the visionaries shaping Arizona’s fast‑growing commercial real estate landscape. The 2026 AZ Big 100 list highlights 50 influential builders, developers, architects, and innovators who are driving sustainable growth, expanding infrastructure, and redefining community-focused design. For professionals in real estate, construction, finance, and related fields, this roundup offers a powerful look at the leadership and trends guiding Arizona’s next era of development.
After years of relentless premium increases, State Farm has filed for a 10% homeowners insurance rate reduction in Florida, signaling that recent legislative reforms may finally be stabilizing the state’s turbulent insurance market. This move could pressure other insurers to follow and marks one of the first meaningful signs of relief for Florida homeowners and real estate professionals.
Illinois has updated its insurance supplier diversity reporting requirements, impacting insurers, HMOs, dental plan corporations, and accredited reinsurers with at least $50 million in admitted assets. Beginning April 1, 2026, companies must use the state’s new PDF template and file through SERFF, following strict formatting rules for procurement, certification types, and diversity goals. The update signals a stronger statewide push for transparency and equitable contracting, making accurate compliance essential for insurance and finance professionals.
YouTube superstar MrBeast has officially moved into the world of finance with his acquisition of Step, a fast‑growing youth money management app backed by Stripe and major venture investors. Now operating under Beast Industries, Step is poised to bring modern financial tools—like credit building, investing, and budgeting—to millions of teens and young adults. With MrBeast’s massive reach and Step’s existing user base of over 7 million, this move could reshape how the next generation learns essential financial skills, giving future professionals a stronger foundation whether they pursue real estate, mortgage, insurance, finance, or any career where smart money decisions matter.
Long Island’s commercial market just hit an all‑time high, closing $4.1 billion in commercial real estate sales across Nassau and Suffolk counties in 2025—a 71 percent jump from the prior year. Specialty-use properties like assisted living and self‑storage led the surge, fueled by lower interest rates and renewed investor confidence.
